Radiofrequency Ablation in the Pain Management of Knee Osteoarthritis

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05303766
Collaborator
(none)
150
1
3
11
13.7

Study Details

Study Description

Brief Summary

The aim of this study is to assess the safety and efficacy of radio frequency thermo-coagulation on the genicular nerve (RFTGN) and intra-articular pulsed radio frequency (IAPRF) for Knee Osteoarthritis (KOA) to improve physical activity , range of joint movement , pain intensity and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Device: Radio-frequency ablation
  • Drug: Intra-articular steroids
  • Device: Pulsed Radio-frequency
N/A

Detailed Description

After obtaining the consent from patients and being informed about the study and potential risks , all patients were randomly assigned to the RFTGN, IAPRF, and intraarticular steroid injection (IAS) groups. All procedures were performed under the guidance of C-arm X-ray machine. The observation indicators of this study were the numeric rating scale (NRS), Oxford knee scale (OKS), and perceived global effect (GPE). The time points for the assessment were 1-week, 1-month, 3-months, 6-months and 9-months after the treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparing the Safety and Effectiveness of Radiofrequency Thermocoagulation on Genicular Nerve, Intraarticular Pulsed Radiofrequency With Steroid Injection in the Pain Management of Knee Osteoarthritis
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: RFT group

The treatment of the patients in the radio frequency thermo-coagulation of the genicular nerves was conducted under the guidance of C-arm X-ray machine . The C-arm machine showed that the radiofrequency cannula needle was advanced percutaneously towards the periosteal areas connecting the shaft of the femur to bilateral epicondyles and the shaft of the tibia to the medial epicondyle while the lateral image showed that the depth of the needle insertion was about 50% of the diameter of the femur or tibia. The radiofrequency electrodes were connected and tested. These induced abnormal pain around the knee joint at 50 Hz and 0.1-0.3 V, but did not induce contraction of the muscles of the knee joint at 2 Hz and > 2.0 V. The location of the needle tip was confirmed by the C-arm, and 0.5 mL of 1% lidocaine was used for local anesthesia. The temperature of RFT was increased gradually to 70°C for 180 seconds.

Device: Radio-frequency ablation
Radiofrequency thermocoagulation of the genicular nerves
Other Names:
  • Radiofrequency generator
  • Experimental: IAPRF group

    The puncture site was selected in the middle of the medial or lateral edge of the patella. After local anesthesia was administered with 0.5% lidocaine, the radiofrequency cannula needle was inserted slowly between the patella and femoral condyles. The needle was gradually inserted into the joint cavity, and then a small volume of saline was administered using a syringe. If any resistance was encountered, which indicated that the needle tip was located in a ligament or tendon, the surgeon readjusted the needle tip until the injection proceeded without any significant resistance. After entering the joint cavity, the C-arm x-ray is used confirm that the cannula needle was located in the middle of the joint space. Subsequently, sensory stimulation using 50 Hz/2 Hz was performed at > 2 V, to prevent inducing pain or muscle contraction. Then, an automatic PRF mode ≤ 45 V (≤ 42°C, 2 Hz, pulse width of 20 ms) was administered for 300 seconds.

    Device: Pulsed Radio-frequency
    Intraarticular Pulsed Radiofrequency of the knee
    Other Names:
  • Radiofrequency generator
  • Experimental: IAS group

    The puncture procedure was similar to that for the IAPRF group. After the cannula needle was inserted to the articular cavity, 1 mL compound betamethasone (2 mg betamethasone sodium phosphate and 5 mg betamethasone dipropionate) was injected. Then, the needle was withdrawn, and the puncture site was dressed aseptically.

    Drug: Intra-articular steroids
    Intra-articular steroids for Knee osteoarthritis
    Other Names:
  • Betafos®
  • Outcome Measures

    Primary Outcome Measures

    1. Numeric rating scale (NRS) [9 months and after procedure]

      Using the numerical rating score , a score from ( 0 to 10 ) for evaluation of pain intensity. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    2. Oxford Knee Score [9 months and after procedure]

      Using oxford knee score for follow up of pain of knee osteoarthritis , a score from 0 to 48 . if the score is 0 to 19 this may indicate sever arthritis , and if it's from 40 to 48 it means satisfactory joint function . This scrore is based on a 12-question report about an individual's level of function, activities of daily living and how they have been affected by pain over the preceding four weeks.

    Secondary Outcome Measures

    1. Duration of pain free periods [9 months and after procedure]

      Duration of pain free periods since the intervention has been done

    2. Site of pain [9 months and after procedure]

      Patients undergo physical knee examination to determine the site of knee pain at right or left knee , medial or lateral joint line

    3. Total consumption of analgesics ( e.g NSAIDS , weak opioids… ect ) [9 months and after procedure]

      Different analgesics used by the patients to alleviate the pain. The patient is asked about how frequent he/she uses an analgesic for pain relief.

    4. Improvement of knee joint function [9 months and after procedure]

      Using The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for evaluation of knee osteoarthritis. t is a self-administered questionnaire consisting of 24 items divided into 3 subscales: 1- Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright. 2-Stiffness (2 items): after first waking and later in the day. 3- Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • Inclusion Criteria:
    1. patients diagnosed with KOA based on the American College of Rheumatology criteria

    2. age 18-70 years

    3. grade 2 or 3 KOA based on the Kellgren-Lawrence classification

    4. patients who did not respond to conservative treatment (physiotherapy, oral NSAIDs, and/or intraarticular injections of hyaluronic acid and corticosteroid) for 3 months

    5. duration of knee pain ≥ 3 months

    6. numeric rating scale (NRS) ≥ 5 points within 24 h prior to admission.

    • Exclusion Criteria:
    1. grade 1 or 4 KOA based on the Kellgren-Lawrence classification

    2. severe liver, kidney, cardiovascular, and respiratory disease

    3. abnormal blood coagulation

    4. skin infections in the puncture region

    5. patients who previously underwent knee arthroscopy, TKA, RFTGN, or IAPRF

    6. mental disorders or inability to complete the follow-up observational form

    7. patients with bilateral knee pain.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Assiut University Hospital Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: Esraa M Osman, MBBCH, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Esraa Mostafa Ali Osman, Principal Investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05303766
    Other Study ID Numbers:
    • Radiofrequency Ablation KOA
    First Posted:
    Mar 31, 2022
    Last Update Posted:
    Apr 13, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 13, 2022